(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(0.46%) $78.47
(0.56%) $2.15
(-0.21%) $2 303.70
(0.58%) $26.85
(-0.57%) $959.80
(-0.02%) $0.929
(-0.20%) $10.85
(-0.06%) $0.797
(0.00%) $91.45
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 6.81%
0.50% $ 10.06
Live Chart Being Loaded With Signals
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland...
Stats | |
---|---|
Dzisiejszy wolumen | 1 000.00 |
Średni wolumen | 4 252.00 |
Kapitalizacja rynkowa | 245.75M |
EPS | $0 ( 2024-03-06 ) |
Następna data zysków | ( $-0.380 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.41 |
ATR14 | $0 (0.00%) |
PROFOUND MEDICAL CORP Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PROFOUND MEDICAL CORP Finanse
Annual | 2023 |
Przychody: | $7.20M |
Zysk brutto: | $4.38M (60.87 %) |
EPS: | $-1.350 |
FY | 2023 |
Przychody: | $7.20M |
Zysk brutto: | $4.38M (60.87 %) |
EPS: | $-1.350 |
FY | 2022 |
Przychody: | $6.68M |
Zysk brutto: | $3.02M (45.22 %) |
EPS: | $-1.380 |
FY | 2021 |
Przychody: | $6.87M |
Zysk brutto: | $2.95M (42.95 %) |
EPS: | $-1.500 |
Financial Reports:
No articles found.
PROFOUND MEDICAL CORP
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej